Is Addus HomeCare Corporation (ADUS) overvalued? · P/E 17, rev $1.15B
Addus HomeCare Corporation (ADUS) is a medical care facilities company listed on NASDAQ.
This page asks whether Addus HomeCare Corporation (ADUS) looks expensive on cached numbers — not a short thesis.
Latest reported ADUS revenue for 2024-12-31 was $1.15B. Net income was $73.6M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. ADUS currently screens at market cap $1.75B and trailing P/E 17.3.
ADUS currently screens at market cap $1.75B and trailing P/E 17.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ADUS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ADUS stock page for the full model, not this heading.
Not investment advice.